review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.CURRPROBLCANCER.2017.02.008 |
P698 | PubMed publication ID | 28583748 |
P50 | author | David Tan | Q58821394 |
P2093 | author name string | Yvonne L E Ang | |
P433 | issue | 4 | |
P304 | page(s) | 273-286 | |
P577 | publication date | 2017-03-14 | |
P1433 | published in | Current Problems in Cancer | Q15756751 |
P1476 | title | Development of PARP inhibitors in gynecological malignancies | |
P478 | volume | 41 |
Q47122646 | Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer |
Q93103171 | Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis |
Q93053468 | Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts |
Q98164379 | Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence |
Q52592609 | Update on PARP Inhibitors in Breast Cancer. |
Search more.